Results 331 to 339 of about 1,103,970 (339)

Colchicine in Acute Myocardial Infarction.

New England Journal of Medicine
BACKGROUND Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events.
Sanjit S. Jolly, M. d’Entremont, Shun Fu Lee, R. Mian, J. Tyrwhitt, S. Kedev, Gilles Montalescot, J. Cornel, G. Stankovic, Raúl Moreno, Robert F. Storey, Timothy D. Henry, S. Mehta, Matthias Bossard, Petr Kala, Jamie Layland, B. Zafirovska, P. Devereaux, J. Eikelboom, John A Cairns, Binita Shah, Tej Sheth, S. K. Sharma, W. Tarhuni, D. Conen, Sarah Tawadros, S. Lavi, Salim Yusuf   +27 more
semanticscholar   +1 more source

Empagliflozin after Acute Myocardial Infarction.

New England Journal of Medicine
BACKGROUND Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease.
Javed Butler, W. S. Jones, Jacob A. Udell, S. Anker, Mark C. Petrie, Josephine L. Harrington, Michaela Mattheus, Isabella Zwiener, Offer Amir, M. Bahit, J. Bauersachs, Antoni Bayés-Genís, Yundai Chen, Vijay K. Chopra, Gemma Figtree, Junbo Ge, Shaun G. Goodman, Nina Gotcheva, S. Goto, Tomasz Gąsior, W. Jamal, J. Januzzi, Myung Ho Jeong, Yuri Lopatin, Renato D. Lopes, Béla Merkely, Puja B. Parikh, A. Parkhomenko, P. Ponikowski, Xavier Rosselló, Morten Schou, Dragan Simić, P. Steg, J. Szachniewicz, P. van der Meer, D. Vinereanu, Shelley Zieroth, Martina Brueckmann, M. Sumin, Deepak L. Bhatt, Adrian F. Hernandez   +40 more
semanticscholar   +1 more source

Acute Infection and Myocardial Infarction.

New England Journal of Medicine, 2019
Risk of MI after Acute Infection Among patients who are hospitalized for pneumococcal pneumonia, the incidence of myocardial infarction is 7 to 8%.
D. Musher, M. Abers, V. Corrales-Medina
semanticscholar   +1 more source

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

The Lancet, 2003
E. Keeley, J. Boura, C. Grines
semanticscholar   +1 more source

Acute myocardial infarction.

Critical care clinics, 2014
A. Ibrahim, Thomas C Riddell, C. Devireddy   +2 more
semanticscholar   +1 more source

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

European Heart Journal, 2012
P. Steg, Stefan James, D. Atar, L. Badano, C. Blömstrom-Lundqvist, Michael A. Borger, C. Di Mario, K. Dickstein, Gregory Ducrocq, Francisco Fernández-Avilés, A. Gershlick, Pantaleo Giannuzzi, S. Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, J. Knuuti, Mattie J Lenzen, K. Mahaffey, M. Valgimigli, Arnoud W.J. van ‘t Hof, Petr Widimsky, D. Zahger   +22 more
semanticscholar   +1 more source

The NLRP3 inflammasome in acute myocardial infarction

Nature Reviews Cardiology, 2018
S. Toldo, A. Abbate
semanticscholar   +1 more source

Acute Myocardial Infarction.

New England Journal of Medicine, 2017
Jeffrey L. Anderson, D. Morrow
semanticscholar   +2 more sources

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

, 1987
Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.
semanticscholar   +1 more source